The Oxford University COVID-19 vaccine undergoing Phase III clinical trials with British pharma giant AstraZeneca is doing 'everything expected' which means good news in the fight against the......
The coronavirus vaccine developed by Oxford University and AstraZeneca “should be” effective against the highly transmissible new strain of the virus, a United Kingdom media report said......
The coronavirus vaccine developed by teams at the University of Oxford has been shown to trigger a robust immune response in healthy adults aged 56-69 and those over 70 years of age. The findings......
Vaccine major Serum Institute of India on Thursday said the COVID-19 vaccine developed by AstraZeneca and Oxford University is safe and effective, and the Indian trials are progressing smoothly......
The University of Oxford has launched the first study to assess the safety and immune responses in children and young adults of its coronavirus vaccine. The university said that previous trials of......
The institute expects to complete both, phase-2 and 3 trials in India by the end of this year. Pune's Serum Institute of India (SII) is all set to start phase-2 clinical trials of the Oxford......
Serum Institute is investing $200 million to create capacities for the COVID-19 vaccine.Sohini Das profiles its 39-year-old CEO. IMAGE: Adar Poonawalla, right, and his father Dr Cyrus S......
'The challenge will be making sure its efficacy is high.''If a vaccine is only 50 to 60 per cent efficient, it's a double-edged sword.' Adar Poonawalla, chief executive officer, Serum Institute of......
'People are already sending congratulatory messages. But I have said, "Please don't until the trials are over".'Ritwik Sharma reports. IMAGE: A quality control test conducted at the Serum......
Serum Institute of India chief Adar Poonawalla will pay £138 million (about Rs 1,444 crore) for a Mayfair mansion in London in one of the city’s most expensive home sales of the year,......